Drug Type Oligonucleotide |
Synonyms Antisense technology-based ARDS program (Lipigon) |
Target |
Mechanism ANGPTL4 modulators(angiopoietin like 4 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Distress Syndrome, Acute | Preclinical | SE | 04 Apr 2023 |